Compounded semaglutide is a version of the medication that is custom-mixed by a pharmacist
MHRA/GOV.UK: First GLP-1 tablet for weight loss approved in the UK
Join us for a free BAC webinar sponsored by Ardent Mills where we'll share: Data from Ardent Mills' quantitative study on GLP-1's impact on baked goods purchasing in Canada and North America A reformulation roadmap using fortified and functional flour products for higher-protein, higher-fibre, lower-sugar offerings A strategic framework to evaluate which SKUs face volume risk and where your opportunity lies The long view on Canadian market penetration and what generic approvals mean for your demand planning over the next 1836 months
Read more Imagine waking up feeling like you didn't sleep at all
Without sufficient methylfolate and vitamin B12, MTR wont convert as much homocysteine to methionine, leading to a buildup of homocysteine and limiting methionine
As with other agents that cause significant weight loss or gastrointestinal fluid losses, there are theoretical class-related risks that warrant attention, including gallbladder disease (cholelithiasis and cholecystitis have been reported with GLP-1 receptor agonists), and dehydration or acute kidney injury in the context of persistent vomiting or diarrhoea
